申请人:Novartis AG
公开号:EP3904366A1
公开(公告)日:2021-11-03
The disclosure relates to nucleic acids that contain modifications at the 5'-end, 3'-end or 5'-end and 3'-ends, and compounds that can be used to make the modified nucleic acids are disclosed. The modified nucleic acids have improved expression, lower immunogenicity and improved stability compared to unmodified nucleic acids.The compounds are of formula (I)
本公开涉及在 5'末端、3'末端或 5'末端和 3'末端含有修饰的核酸,并公开了可用于制造修饰核酸的化合物。与未修饰的核酸相比,修饰的核酸具有更好的表达能力、更低的免疫原性和更高的稳定性。